Does LOSARTAN Cause Malignant neoplasm progression? 56 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Malignant neoplasm progression have been filed in association with LOSARTAN (Losartan Potassium). This represents 0.3% of all adverse event reports for LOSARTAN.
56
Reports of Malignant neoplasm progression with LOSARTAN
0.3%
of all LOSARTAN reports
12
Deaths
33
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LOSARTAN?
Of the 56 reports, 12 (21.4%) resulted in death, 33 (58.9%) required hospitalization, and 9 (16.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOSARTAN. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does LOSARTAN Cause?
Drug ineffective (1,640)
Dizziness (1,553)
Headache (1,256)
Dyspnoea (1,185)
Malaise (1,149)
Hypotension (1,139)
Fatigue (1,116)
Acute kidney injury (1,100)
Cough (1,073)
Blood pressure increased (950)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LOSARTAN Alternatives Have Lower Malignant neoplasm progression Risk?
LOSARTAN vs LOSARTAN\LOSARTAN
LOSARTAN vs LOTEPREDNOL ETABONATE
LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN
LOSARTAN vs LOTILANER
LOSARTAN vs LOVASTATIN